Skip to main content
AKAN
NASDAQ Life Sciences

Akanda Corp. Registers Over 30 Million Shares for Resale, Enabling Massive Dilution from Recent Convertible Note Offering

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$1.73
Mkt Cap
$3.643M
52W Low
$1.19
52W High
$46.45
Market data snapshot near publication time

Summary

Akanda Corp. filed an F-1 registration statement for the resale of up to 30.3 million common shares, which are issuable upon conversion of the recently finalized $7.0 million convertible notes, signaling substantial future dilution.


Key Events

  • Resale Registration Filed

    Akanda Corp. filed an F-1 to register 30,314,961 common shares for resale by selling stockholders.

  • Enables Prior Dilutive Offering

    These shares are issuable upon conversion of the $7.0 million convertible notes, which were finalized on January 23, 2026. This filing makes those shares eligible for public trading.

  • Significant Potential Dilution

    The number of shares registered for resale is approximately 14 times the current outstanding common shares, indicating a massive potential dilutive impact on existing shareholders.

  • Going Concern Context

    This capital raise and subsequent resale registration occur as the company's financial statements express "substantial doubt about its ability to continue as a going concern."


Analysis

This F-1 filing registers 30,314,961 common shares for resale by selling stockholders, stemming from the $7.0 million convertible note offering finalized on January 23, 2026. This registration is a critical procedural step that enables the conversion of these notes into common shares and their subsequent sale in the public market. The potential issuance of over 30 million shares represents an extremely high level of dilution compared to the approximately 2.1 million shares currently outstanding. While the convertible note offering provided much-needed capital to a company facing significant operating losses and going concern doubts, the sheer volume of shares now registered for resale creates a substantial overhang on the stock, likely exerting significant downward pressure on the share price. Investors should be aware of the severe dilutive impact this will have on existing shareholder value.

At the time of this filing, AKAN was trading at $1.73 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.6M. The 52-week trading range was $1.19 to $46.45. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AKAN - Latest Insights

AKAN
Jun 12, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.35
Real-time Price: $18.50 info
Change: +$3.15 (+21%) info
Market Cap: $10.027M info
AKAN
Jun 09, 2026, 4:15 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $13.76
Real-time Price: $18.50 info
Change: +$4.74 (+34%) info
Market Cap: $10.027M info
AKAN
May 22, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $26.38
Real-time Price: $18.50 info
Change: -$7.88 (-30%) info
Market Cap: $10.027M info
AKAN
May 22, 2026, 2:00 PM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $23.75
Real-time Price: $18.50 info
Change: -$5.25 (-22%) info
Market Cap: $10.027M info
AKAN
May 13, 2026, 5:27 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $25.00
Real-time Price: $18.50 info
Change: -$6.50 (-26%) info
Market Cap: $10.027M info
AKAN
Apr 29, 2026, 8:30 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $20.15
Real-time Price: $18.50 info
Change: -$1.65 (-8%) info
Market Cap: $10.027M info
AKAN
Apr 10, 2026, 5:15 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.6397
Real-time Price: $18.50 info
Change: +$17.86 (+2,792%) info
Market Cap: $10.027M info
AKAN
Apr 09, 2026, 11:50 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.690
Real-time Price: $18.50 info
Change: +$17.81 (+2,581%) info
Market Cap: $10.027M info
AKAN
Apr 09, 2026, 8:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.6897
Real-time Price: $18.50 info
Change: +$17.81 (+2,582%) info
Market Cap: $10.027M info
AKAN
Apr 07, 2026, 4:52 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.675
Real-time Price: $18.50 info
Change: +$17.83 (+2,641%) info
Market Cap: $10.027M info